Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.
In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.
Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.
Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.
University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.
In Science this week: new chromatin imaging approach, and more.
A 'de-extinction' approach may help increase genetic diversity of the black-footed ferret, Scientific American says.
Researchers develop a Qatari reference genome to boost precision medicine in Middle Eastern populations.
Arizona State University's James Collins writes at Slate for the need to better study gene-drive technology before its use.
In Nature this week: sequence and analysis of modern and ancient barley, comparative genomic analysis of mucormycosis, and more.
Seven UK academies say a "bold commitment" is needed from the government to keep British research and innovation strong in the wake of the Brexit vote.
James Watson tells Stat News that the Cancer Moonshot Initiative is "crap."
Researchers have isolated and sequenced a bacterium from the marine sulfur-oxidizing bacteria clade SUP05.
In Genome Research this week: molecular autopsies for sudden death, telomere methylation in Arabidopsis, and more.
In a preprint, Craig Venter's team reports sequencing the genomes of 10,500 people to between 30X and 40X coverage.
A cancer patient with a rare BRCA1 variant seeks better data sharing, Newsweek reports.
In Australia, US Vice President Joe Biden touts cancer patient data sharing and more.
In PNAS this week: mouse lemurs phylogenetics informs geographic study, DXZ4 needed for inactive X chromosome packaging, and more.
Precision medicine is still years away, if it's achievable at all, according to Technology Review.
Researchers are expanding the use of fecal transplants while also trying to figure out what component of poop makes them effective.
Insurers are more willing to cover whole-exome sequencing, Dark Daily writes.
In PLOS this week: host factors affecting necrotizing soft tissue infection susceptibility, effectiveness of low-coverage sequencing in NIPT, and more.
Columbia University settles a civil fraud lawsuit that said it improperly used its on-campus indirect cost rate when seeking reimbursement for more than 400 grants.
In the journal Genetics, a research pair examines the evolutionary fitness of Neanderthals.
Jonathan Eisen gives his 'Overselling the Microbiome' award to the New York Times for its thumb-sucking and nail-biting story.
The US National Labor Relations Board rules that graduate assistants have the right to unionize.
Sociologists find that dual-career programs are important for recruiting female academics, Inside Higher Ed reports.
Many more PhDs are produced in the sciences than there are tenure-track professor positions, the New York Times reports.
The Huffington Post explores why female graduate students might not report sexual harassment.